# Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)

> **NCT01534312** · NA · COMPLETED · sponsor: **University of Aarhus** · enrollment: 24 (actual)

## Conditions studied

- Colitis, Ulcerative
- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** CGMP protein
- **DRUG:** Maximal oral 5ASA

## Key facts

- **NCT ID:** NCT01534312
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2014-09
- **Final completion:** 2014-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01534312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01534312, "Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01534312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*